Cellular and humoral immune response to mRNA COVID-19 vaccination in subjects with chronic lymphocytic leukemia

Blood Adv. 2022 Feb 22;6(4):1207-1211. doi: 10.1182/bloodadvances.2021006633.
No abstract available

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • COVID-19 Vaccines
  • COVID-19*
  • Humans
  • Immunity, Humoral
  • Leukemia, Lymphocytic, Chronic, B-Cell* / genetics
  • RNA, Messenger / genetics
  • SARS-CoV-2
  • Vaccination

Substances

  • COVID-19 Vaccines
  • RNA, Messenger